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1. Introduction 
Intravascular Ultrasound (IVUS) is an invasive grey scale tomographic imaging modality 
providing cross-sectional images of the vessel wall. The reflected or scattered ultrasound 
signal received at the transducer is converted to a voltage. This voltage is known as 
radiofrequency data or backscattered signal. The time delay and amplitude of these emitting 
pulses provides 256 such backscattered signals or A-scans to produce one image. For IVUS 
imaging, high ultrasound frequencies typically centred between 25-50 MHz are used. The 
size of conventional IVUS catheter is 2.9 and 3.5 Fr and has a typical pullback speed of 0.5 
mm/s and a frame rate of 30 images per second. At 30 MHz the wavelength is 50 m, which 
yields a spatial resolution of >150m allowing detail evaluation of the blood vessel wall.  
IVUS imaging is complementary to coronary angiography and allows the simultaneous 
assessment of lumen and components of the vessel wall. In the IVUS image the catheter is in 
the centre of the image surrounded by vessel lumen, the three layers of the vessel and 
surrounding structures (Figure 1). It can assess plaque geometry including plaque burden 
and size, luminal area, longitudinal extent of the disease, circumferential extent of the 
 
 
Fig. 1. IVUS of normal coronary artery 
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plaque, arterial remodelling and plaque vulnerability. Therefore IVUS provides detailed 
insight to the anatomy of plaque burden and allows the interventional cardiologist to adapt 
an optimal strategy for percutaneous coronary intervention (PCI) and subsequently assess 
the success of this strategy.  In this chapter we will describe the potential applications of 
IVUS for every day use in the catheterization laboratory.   
2. Clinical applications of IVUS 
2.1 Assessment of vessel size for stent selection and ischemia evaluation 
Standard coronary angiography is intrinsically limited to evaluate three-dimensional 
anatomical coronary cross sectional area due to planar silhoutte imaging. In addition, the 
plaque burden, its delineation and constituents cannot be assessed by coronary 
angiography. With angiography, the severity of stenosis is assessed by minimal lumen 
diameter at the lesion site, in comparison with an adjacent normal appearing reference. 
However, it is well documented that atherosclerosis is diffuse in nature and may appear 
normal in a small calibre coronary artery with concentric plaque (Figure 2)(Grondin, Dyrda 
et al. 1974; Roberts and Jones 1979). IVUS provides a complete 360 degrees tomographic 
view that allows accurate lumen measurements. In fact direct comparison of atherosclerotic 
disease by angiography and IVUS are frequently discrepant often as a result of eccentric 
plaque.(Figure 2) IVUS studies have clearly demonstrated that there is no correlation 
between the size of the atheroma and the size of the lumen(Topol and Nissen 1995) . This 
difference can be explained by positive (expansive) remodelling where lumen size is 
maintained due to plaque accumulation within in the vessel wall and resulting vessel wall 
expansion. It is claimed that these positive plaques are more unstable and vulnerable to 
rupture than negative (constrictive) plaques and also responsible for in-stent restenosis (ISR) 
following coronary intervention.(Schoenhagen, Ziada et al. 2000).  
 
 
    
 
Fig. 2. IVUS images of A) concentric plaque and B) eccentric plaque 
A B 
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In addition to accurate stent sizing, IVUS can be used to evaluate lesion lumen area to 
predict the presence or absence of myocardial ischemia and/or significant coronary 
stenosis. There was strong correlation between lesion lumen area of  4.0 mm2 on IVUS 
and positive stress myocardial perfusion SPECT in seventy native coronary lesions 
(Nishioka, Amanullah et al. 1999). In another study, IVUS guided deferral of coronary 
intervention of 248 lesions with luminal area of 4 mm2 resulted in clinical rates of 4.4% 
and target lesion revascularisation (TLR) of 2.8% at 12 month follow up. (Abizaid, Mintz 
et al. 1998).  
2.2 Assessment of restenosis 
Following coronary intervention, the formation of neointimal hyperplasia is mainly 
responsible for ISR (Figure 3). There is strong correlation with between late lumen loss and 
the degree of in-stent neointimal growth (r=0.98) (de Jaegere, Mudra et al. 1998; Hoffmann, 
Mintz et al. 1998). Although drug eluting stents (DES) has significantly reduced the 
incidence of neointimal proliferation, the rate of ISR still remains around 10-15%. 
 
 
Fig. 3. IVUS image of in-stent restenosis 
One of the main factors for ISR is stent underexpansion (Figure 4). IVUS can detect vessel 
stent subtleties not apparent by coronary angiography. In addition to assessing plaque 
geometry, IVUS can be used to achieve complete stent apposition and adequate geometric 
expansion within the stented segment. IVUS studies have demonstrated that incomplete 
stent and vessel wall apposition, residual stenosis and irregular eccentric lumen in the 
stented segment was present in almost 88% of the patients despite achieving an optimal 
angiographic result (Nakamura, Colombo et al. 1994) . Clinical trials have shown that 
patients who have their coronary intervention guided by IVUS have larger post procedure 
stent areas and significant reductions in TLR as compared to angiography-guided PCI alone 
(de Jaegere, Mudra et al. 1998; Schiele, Meneveau et al. 1998; Fitzgerald, Oshima et al. 2000; 
Sonoda, Morino et al. 2004; Hong, Mintz et al. 2006) In addition to detecting stent 
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underexpansion, IVUS can also assist in achieving optimal stent expansion, exclude stent 
edge dissections and plaque protrusion (Hong, Jeong et al. 2008). 
 
 
Fig. 4. IVUS demonstrating A) stent well  apposed to vessel wall and B) stent mal-apposition 
2.3 Guidance for left main stem intervention  
Coronary interventions of unprotected left main coronary artery (UPLM) with bare metal 
stents in the 1990s were associated with high rates of revascularization (25% to 30%) due to 
restenosis (Black, Cortina et al. 2001; Park, Hong et al. 2001; Takagi, Stankovic et al. 2002). 
Although the use of DES for UPLM PCI have significantly reduced the rate of 
revascularization as compared with bare metal stents (BMS), the long term outcomes remain 
less favourable. Most of the poor outcomes following UPLM PCI relates to distal bifurcation 
intervention, which is a technically complex procedure. The current American College of 
Cardiology (ACC)/American Heart association (AHA) practice guidelines for PCI 
categorize UPLM stenting as a class IIb indication or IIa indication in selected patients 
without co-existing multivessel disease. At present there is a paucity of randomized control 
trial data comparing Coronary artery bypass grafting (CABG) to PCI in patients with UPLM. 
The best available evidence comes from the SYNTAX trial (SYNergy between Percutaneous 
Coronary Intervention with TAXus and Cardiac Surgery), which randomly assigned 1800 
patients with either UPLM (n=705) or multivessel CAD not involving the left main stem 
(n=1095) (Ong, Serruys et al. 2006) . The major adverse cardiac or cerebrovascular events 
were not significantly different between the CABG and PCI groups (13.7 vs 15.8%). 
However, the rate of revascularization was significantly higher in those treated with PCI 
(11.8 vs 6.5 %). One of the main limitations of the SYNTAX trial was felt to be the lack of use 
of IVUS for UPLM in the PCI group. 
While the European Society of Cardiology guidelines give IVUS-guided stenting of the 
UPLM a Class IIb recommendation we feel IVUS interrogation of the UPLM pre and post 
intervention should be used in all cases. Not least because IVUS interrogation has been 
demonstrated to, frequently prove angiographic assessment of the UPLM as inaccurate. This 
obviously may have significant impact on patient management resulting in either erroneous 
A B 
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treatment of a lesion which may appear severe angiographically but in fact has minimal 
plaque burden or failure to treat lesions which are mis-labelled as mild-to-moderate (Mintz 
and Maehara 2009). 
Moreover, IVUS is an ideal method for confirming the presence of significant left main 
disease and also for guiding selection of stent size, assessing the presence and extent of 
calcification and especially evaluating the distal left main vessel and its branches. IVUS 
assessment pre and post left main intervention is very important to evaluate larger lumen 
area of the ostial and midshaft left main and adequate post dilatation post stenting. In 
comparison to native coronary vessels, a minimal luminal area of <6.0 mm2 is a commonly 
used threshold for significant left main disease (Sano, Mintz et al. 2007). While there are no 
randomized trials to inform practice in this area, registry data has shown a trend toward 
reduced mortality in IVUS guided UPLM PCI.(Park, Kim et al. 2009)  
2.4 Guidance for Chronic Total Occlusion (CTO) intervention 
CTOs are the most complex lesions that are considered for percutaneous coronary 
revascularization. PCI of CTO results in symptomatic improvement, improved left ventricle 
function and reduction in adverse remodelling. In addition recanalization of CTO leads to 
long-term survival benefit and avoidance of bypass surgery (Melchior, Doriot et al. 1987; 
Ivanhoe, Weintraub et al. 1992; Chung, Nakamura et al. 2003; Cheng, Selvanayagam et al. 
2008). The number of CTO interventions has risen gradually due to better operator experience, 
technical improvements, and newer procedural techniques (these include contra-lateral 
coronary injection, “parallel” wire techniques, subintimal tracking and re-entry (STAR), 
retrograde approach with control antegrade retrograde tracking (CART), reverse CART). 
Despite these advances, the success rate of CTO interventions remains low (<60%)(Di Mario, 
Werner et al. 2007), largely due to difficulty crossing the occlusion with the guidewire and 
entering the true distal lumen beyond the occlusion (Safian, McCabe et al. 1988; Kinoshita, 
Katoh et al. 1995). In most instances of failed CTO intervention, the guidewire enters the false 
lumen (subintimal space) at the site of occlusion, often making it impossible to re-enter the 
true lumen (Figure 5). CTO interventions can be performed via an antegrade approach or 
retrograde approach using septal collaterals (Surmely, Tsuchikane et al. 2006).  
IVUS studies provide insights into the anatomy of the CTO lesion. In one report IVUS 
demonstrated presence of calcium mostly across the side branch take-off, especially in 
abrupt-origin CTOs (Fujii, Mintz et al. 2006). This anatomical variance can explain the 
preferential entry of the guidewire into the side branch at the point of occlusion.  The use of 
IVUS for CTO interventions can be extremely useful especially in ensuring that the 
guidewire is positioned within the coronary lumen (true or false), and also helps to identify 
the optimal entry point within the CTO cap(Ochiai, Ogata et al. 2006). IVUS can help to 
avoid subintimal stenting during CTO intervention as this has been reported to result in 
stent thrombosis and stent mal-apposition due to the formation of multiple aneurysms 
(Erlich, Strauss et al. 2006; Tsujita, Maehara et al. 2009). IVUS imaging for CTO can also 
detect vessel wall haematoma, dissection and small perforations that are not detected by 
routine coronary angiography. Further advances in IVUS technology especially the 
development of ‘forward facing IVUS’ will significantly improve our anatomical 
understanding of the chronically occluded lumen. Although IVUS guided intervention of 
chronic occlusions may enhance procedural outcome, the current use of this technology for 
CTO intervention is limited only to experienced operators.  
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Fig. 5. IVUS image of false lumen 
2.5 Guidance for bifurcation lesion intervention 
PCI of bifurcation lesions have been associated with lower procedural success rate and 
worse clinical outcome than when used to treated non-bifurcation lesions. This is largely 
related to the complexity of the bifurcation lesions, significant anatomical variation of the 
bifurcation lesion, and lack of standard guidelines for the treatment of bifurcation lesions. 
The current therapeutic strategies for bifurcation lesions have mainly stemmed from 
personal clinical experience of the operators. (Suzuki, Angiolillo et al. 2007). In recent years 
there has been better understanding of bifurcation lesions especially with use of DES, 
acceptance of provisional stenting (acceptance of a suboptimal result in a small side branch 
SB), specific treatment of bifurcation lesions with a two-stent strategy and increasing use of 
final kissing balloon. The use of IVUS for bifurcation lesions can provide valuable 
information especially in anatomical evaluation of plaque burden, plaque location, angle 
assessment, lumen size of main branch [MB] and [SB]. In addition post PCI, IVUS can assist 
in evaluation of plaque shift, change in carina angle, dissection, and above all optimal stent 
deployment (Costa, Mintz et al. 2005). We feel that IVUS guided optimization of the 
bifurcation lesion post intervention, especially the ostium of a large side branch will 
enhance long term outcome of these technically challenging subset of lesions.  
2.6 Vulnerable plaque assessment 
The composition of atherosclerotic plaque is heterogeneous by nature and contains 1) 
fibrocellular components (extracellular matrix and smooth muscle cells), 2) lipid-cellular 
components (crystalline cholesterol and cholesterol esters mixed with macrophages), 3) 
thrombotic components (platelets and fibrin) and 4) calcium (Figure 6) (Fuster, Badimon et 
al. 1992; Fuster, Badimon et al. 1992; Stary 2000; Virmani, Kolodgie et al. 2000). Vulnerable 
plaques that result in rupture have been now well described as thin cap fibroatheroma 
(TCFA). 
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Fig. 6. IVUS image of atherosclerotic plaque 
Ultrasound provides some information about the morphological features of atherosclerotic 
plaque. The American College of Cardiology Clinical Expert Consensus Document for IVUS 
imaging has described that a vulnerable plaque can appear as an ‘echolucent’ plaque (Mintz, 
Nissen et al. 2001). Frequently these echolucent plaques have a prominent echogenic border 
at the lumen-intima interface. This may correspond to the TCFA. However, it should be 
emphasized that the fibrous cap of TCFA is <65 m and therefore could not be detected 
using this modality. Imaging IVUS provides limited insight into the chemical composition of 
the plaque and is dependent on simple interpretation of acoustic reflections. Lipid-laden 
echolucent plaques can be detected with a sensitivity of between 78% and 95% and 
specificity of 30% (Mallery, Tobis et al. 1990; Potkin, Bartorelli et al. 1990). Furthermore, 
reduced echogenicity may also be observed in large necrotic zones, intramural hemorrhage 
or a thrombus.  
Echodense plaques have an intermediate echogenicity between echolucent and highly 
echogenic calcified plaques. The echodensity of plaques correlate well with plaque fibrosis 
in histological studies. The identification of echolucent plaques is subjective and no 
prospective clinical trials are available. In an IVUS based study, echolucent plaque was 
identified in 31 patients from a total of 144 patients. Of these 31 patients, 23 patients (74%) 
presented with unstable angina. Plaque rupture was confirmed by injecting contrast with 
subsequent filling of the plaque cavity on IVUS (Ge, Haude et al. 1995). In another study, 
IVUS images of 114 coronary lesions with <50% stenosis were recorded and followed up for 
two years.(Yamagishi, Terashima et al. 2000). The patients who developed Acute coronary 
syndrome during the follow up were identified and events correlated with large echolucent 
zones in the eccentric plaques at the time of their first IVUS study. These plaques had 
histological features similar to vulnerable plaques and were associated with increased risk 
of instability. In addition,  IVUS can also identify vulnerable plaques at high risk of rupture 
in vessels with adaptive remodelling (von Birgelen, Klinkhart et al. 2001).  
IVUS has excellent blood penetration and in the absence of calcium is able to visualize and 
calculate plaque area, volume and eccentricity. The use of IVUS to identify TCFA and lipid 
pool is at present limited. It suffers from signal attenuation and geometric effects that result 
in different backscatter signal properties from similar tissues due to differences in tissue 
www.intechopen.com
 Intravascular Ultrasound 102 
orientation and position relative to the imaging transducer.  Ultra- high frequency catheters 
can be employed to achieve high resolution and visualize subluminal fibrous cap, while 
low-resolution components can be used for better penetration of the plaque to assess plaque 
components. 
The conventional IVUS image undergoes considerable processing such as envelope 
detection, time-gain compensation, and logarithmic compression to create real time 
imaging. However, this processing significantly reduces the ability to characterize the 
imaged tissue, the echogenicity of the imaged tissue is difficult to repeat and interpret 
quantitatively. The reflected unprocessed ultrasound signal in the form of A-scan or 
individual backscattered signals (256 A scans for an image) is called the radiofrequency data 
and it is the analysis of these individual A-scans that holds potential for tissue 
characterization. This imaging modality is known as IVUS virtual histology (IVUS –VH) or 
IVUS radiofrequency (IVUS-RF). 
Ex-vivo studies have demonstrated that raw backscattered ultrasound signal allows a more 
detailed analysis of the vessel components with scope to identify different tissue 
morphology (Moore, Spencer et al. 1998). IVUS-VH uses spectral analysis of radiofrequency 
data to construct tissue maps that classify plaque into four major components (fibrous 
[labeled green], fibrolipidic [labeled greenish-yellow], necrotic core [labeled red] and 
calcium [labeled white]) which were correlated with a specific spectrum of the 
radiofrequency signal and assigned color codes (Nair, Kuban et al. 2001). In a clinical study, 
IVUS-VH was used to investigate the presence of IVUS-derived thin cap fibroatheroma 
(IDTCFA) in non-culprit, non-obstructive (<50%) lesions in 55 patients who presented with 
acute coronary syndrome (Rodriguez-Granillo, Garcia-Garcia et al. 2005). The axial 
resolution of the IVUS-VH is between 100 to 150 m and therefore in this study the authors 
assumed that the absence of visible atheroma tissue overlying a necrotic core would suggest 
a cap thickness of below 100 to 150 m and used the absence of such tissue to define a thin 
fibrous cap. In this study, IDTCFA was defined and identified as a lesion with a necrotic 
core ≥10% without evident overlying fibrous tissue and percent atheroma volume (PAV) 
≥40%. In this study significantly higher prevalence of IDTCFA was observed in patients 
with Acute coronary syndrome in comparison with controls [(3.0 IQR 0.0 to 5.0 vs. 1.0 IQR 
1.0 to 2.8) p=0.018]. The large multicenter PROSPECT trial (700 patients with Acute coronary 
syndrome) looked at long-term outcomes of non-culprit lesions (based on IVUS-VH) at the 
time of Percutaneous coronary intervention of the culprit lesions. The investigators reported 
that only 11 percent of the patients had high event rate (i.e. 17%) in association with thin-
capped fibroatheromas  with minimal luminal area (MLA) 4 mm2 and plaque burden 
70%. Although high-risk focal sites can be detected with IVUS-VH, the predictive power 
(significantly higher numbers of vulnerable plaques than clinical events) of vulnerable 
plaque to cause a clinical event remains low.  
IVUS-RF data acquisition and real time processing with three dimensional imaging and 
spectral analysis is a potential tool to assess vulnerable plaque in vivo. This imaging tool 
provides detailed volumetric assessment of the histological components of the plaque in vivo 
and therefore may represent a unique technique to identify the vulnerable plaque in future.  
3. Conclusion 
Over the past decade there has been a significant technological advance in cardiovascular 
imaging that has changed the way we assess coronary atherosclerosis and approach 
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coronary intervention.  IVUS is a validated clinical tool that allows precise evaluation of 
angiographically stenotic lesions helping guide the cardiologist’s approach to 
revascualisation and assess complications and sub-optimal results post-procedure. In 
addition it provides important information regarding non-critical but vulnerable plaque 
which is not appreciable by traditional coronary angiography. In an era of more complex 
and ambitious coronary intervention IVUS is a vitally important addition to the 
interventionalist’s armamentarium. In this chapter we have briefly described the various 
potential uses of IVUS and their clinical application. 
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